Similarly, prior studies have verified that high CCL2 expression correlates with poor CRC prognosis [13], while abnormally elevated CCL21 expression is closely associated with poor outcomes in extrahepatic cholangiocarcinoma [38]. The gene discussed is CCL2; the disease is colorectal carcinoma.